[go: up one dir, main page]

NO20043000L - Et preparat for behandling av nevrocerebrovaskulaere sykdommer - Google Patents

Et preparat for behandling av nevrocerebrovaskulaere sykdommer

Info

Publication number
NO20043000L
NO20043000L NO20043000A NO20043000A NO20043000L NO 20043000 L NO20043000 L NO 20043000L NO 20043000 A NO20043000 A NO 20043000A NO 20043000 A NO20043000 A NO 20043000A NO 20043000 L NO20043000 L NO 20043000L
Authority
NO
Norway
Prior art keywords
neurocerebrovascular
diseases
preparation
treatment
neurocerebrovascular diseases
Prior art date
Application number
NO20043000A
Other languages
English (en)
Other versions
NO332066B1 (no
Inventor
Satyawan Singh
Madhur Ray
Raghwendra Pal
Nandoo Mal Khanna
Original Assignee
Council Scient Ind Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council Scient Ind Res filed Critical Council Scient Ind Res
Publication of NO20043000L publication Critical patent/NO20043000L/no
Publication of NO332066B1 publication Critical patent/NO332066B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Mycology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
NO20043000A 2001-12-14 2004-07-13 Et preparat anvendelig for behandling av nevrocerebrovaskulaere sykdommer, samt anvendelse av nevnte preparat til fremstilling av et medikament for behandling av nevrocerebrovaskulaere sykdommer. NO332066B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34016501P 2001-12-14 2001-12-14
PCT/IB2002/005366 WO2003051380A2 (en) 2001-12-14 2002-12-14 Compositions containeing curcuma extracts for the treatment of neurocerebrovascular disorders

Publications (2)

Publication Number Publication Date
NO20043000L true NO20043000L (no) 2004-07-13
NO332066B1 NO332066B1 (no) 2012-06-18

Family

ID=23332163

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043000A NO332066B1 (no) 2001-12-14 2004-07-13 Et preparat anvendelig for behandling av nevrocerebrovaskulaere sykdommer, samt anvendelse av nevnte preparat til fremstilling av et medikament for behandling av nevrocerebrovaskulaere sykdommer.

Country Status (19)

Country Link
US (2) US20060051438A1 (no)
EP (1) EP1453528B1 (no)
JP (1) JP4695839B2 (no)
KR (1) KR101001815B1 (no)
CN (1) CN100528149C (no)
AU (2) AU2002348802A1 (no)
BR (1) BR0214962A (no)
CA (1) CA2473874C (no)
DE (1) DE60233069D1 (no)
EA (1) EA007067B1 (no)
EE (1) EE05374B1 (no)
GE (1) GEP20084442B (no)
LT (1) LT5284B (no)
LV (1) LV13250B (no)
MX (1) MXPA04005680A (no)
NO (1) NO332066B1 (no)
UA (1) UA82057C2 (no)
WO (1) WO2003051380A2 (no)
ZA (1) ZA200404648B (no)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1752144A4 (en) * 2004-05-31 2007-07-11 Kaneka Corp AGENT FOR PREVENTING / IMPROVING LIFESTYLE DISEASES CONTAINING AN ESSENTIAL CURCUMA OIL COMPONENT
JPWO2006118079A1 (ja) * 2005-04-28 2008-12-18 新 山崎 皮膚の老化防止剤
US8859020B2 (en) 2005-05-30 2014-10-14 Benny Antony Treatment of alzheimer's with a curcuminoid mixture and essential oil of turmeric having 45% Ar-turmerone
US12053438B2 (en) 2005-05-30 2024-08-06 Arjuna Natural Private Limited Formulation of curcuminoids with enhanced bioavailability of curcumin, demethoxycurcumin, bisdemethoxycurcumin and method of preparation and uses thereof
US7883728B2 (en) 2005-05-30 2011-02-08 Arjuna Natural Extracts, Ltd. Composition to enhance the bioavailability of curcumin
US10286027B2 (en) 2005-05-30 2019-05-14 Arjuna Natural Extracts, Ltd. Sustained release formulations of curcuminoids and method of preparation thereof
US10543277B2 (en) 2005-05-30 2020-01-28 Arjuna Natural Private Limited Formulation of curcumin with enhanced bioavailability of curcumin and method of preparation and treatment thereof
US9492402B2 (en) 2005-05-30 2016-11-15 Benny Antony Formulation of curcuminoids with enhanced bioavailability of curcumin, demethoxycurcumin, bisdemethoxycurcumin and method of preparation and uses thereof
WO2006129323A1 (en) 2005-05-30 2006-12-07 Antony Benny A composition to enhance the bioavailability of curcumin
JP4980626B2 (ja) * 2006-02-28 2012-07-18 ポーラ化成工業株式会社 プラスミノーゲンアクチベーターインヒビターｉ阻害剤及びそれを配合してなる食品組成物
JP5207341B2 (ja) * 2006-10-26 2013-06-12 独立行政法人産業技術総合研究所 炎症性サイトカイン産生抑制剤
WO2009043176A1 (en) * 2007-10-03 2009-04-09 Sabell Corporation Herbal compositions and methods for treating hepatic disorders
CN102340990B (zh) * 2009-03-05 2015-03-04 关键基因股份有限公司 基于r-姜黄烯的植物挥发性物质
RU2012107457A (ru) 2009-07-31 2013-09-10 Когнишн Терапьютикс, Инк. Ингибиторы ухудшения когнитивных способностей
JP5764288B2 (ja) 2009-09-24 2015-08-19 ハウス食品グループ本社株式会社 ウコン抽出物とガジュツ抽出物とを含有する組成物
JP5578822B2 (ja) * 2009-09-25 2014-08-27 株式会社ピカソ美化学研究所 アセチルコリンエステラーゼ阻害剤
BR112013019775A2 (pt) 2011-02-02 2017-04-18 Cognition Therapeutics Inc composto, composição farmacêutica e método para tratar declínio cognitivo ou doença de alzheimer em um paciente
US9068141B2 (en) 2011-03-29 2015-06-30 Council Of Scientific & Industrial Research Process for the modification of Curcuma aromatica essential oil
GB201111319D0 (en) 2011-07-04 2011-08-17 Univ Leuven Kath Anticonvulsant activity of tumeric oil and bisabolene sesquiterpenoids of curcuma longa
KR101792031B1 (ko) * 2012-01-13 2017-10-31 주식회사 엘지생활건강 피부 주름 개선 및 탄력 증진용 조성물
CN102697757B (zh) * 2012-05-18 2014-06-04 广州军区广州总医院 对羟基苄叉丙酮在制备预防和/或治疗脑病药物中的应用
JP2014201528A (ja) * 2013-04-02 2014-10-27 クラシエ製薬株式会社 抗酸化剤
DK3498692T3 (da) 2014-01-31 2022-05-16 Cognition Therapeutics Inc Isoindolin-sammensætninger og fremgangsmåder til behandling af neurodegenerativ sygdom og makulær degeneration
CN106822071B (zh) * 2014-09-23 2019-12-27 桂林八加一药业股份有限公司 一种用于治疗冠心病、高脂血症的中药有效部位、制备方法及从中分离有效成分的方法
CN105738546B (zh) * 2014-12-12 2020-01-21 桂林八加一药业股份有限公司 毛郁金药材指纹图谱的建立方法及其指纹图谱
CN105055449B (zh) * 2015-07-27 2019-08-09 中国科学院西北高原生物研究所 一种具有抗炎镇痛活性的塞隆骨提取物、制备方法及中药制剂
CN106492137A (zh) * 2016-12-29 2017-03-15 王明金 一种治疗抑郁症的中药组合物及其制备方法
CN106511784A (zh) * 2016-12-29 2017-03-22 王明金 一种治疗精神疾病的中药组合物及其制备方法
CN106491996A (zh) * 2016-12-29 2017-03-15 王明金 一种治疗狂躁症的中药组合物及其制备方法
CN106491997A (zh) * 2016-12-29 2017-03-15 王明金 一种抗精神障碍的中药组合物及其制备方法
JPWO2018207910A1 (ja) * 2017-05-12 2020-03-12 ハウスウェルネスフーズ株式会社 抗炎症用組成物
IL270251B2 (en) 2017-05-15 2025-01-01 Cognition Therapeutics Inc 1-Phenyl-1,1-dimethyl-2-(piperidinyl/pyrrolidinyl/piperazinyl)ethane derivatives and pharmaceutical preparations containing them
US10391138B2 (en) * 2017-07-11 2019-08-27 Muniyal Ayurvedic Research Centre Multidimensional approach for Cancer treatment
CN108498755B (zh) 2018-04-17 2021-04-09 贾洪章 治疗心脑血管疾病的中药组合物及其制备方法和用途
WO2020004357A1 (ja) * 2018-06-29 2020-01-02 ハウスウェルネスフーズ株式会社 アルツハイマー病の治療、予防又は改善用組成物、脳神経細胞死の抑制用組成物、アミロイドβペプチドで誘導されるミクログリアの活性化の抑制用組成物、及び、アミロイドβペプチドで誘導されるＰＧＥ２、ＴＮＦ－α又はＩＬ－１β産生の抑制用組成物
CN111617059B (zh) * 2020-05-29 2023-07-25 广东工业大学 莪术二酮的应用
CN111617060A (zh) * 2020-05-29 2020-09-04 广东工业大学 吉马酮的应用
JP7637357B2 (ja) * 2020-09-29 2025-02-28 学校法人近畿大学 血管保護のためのターメリックオイルを含有する組成物、ならびにこのような組成物を含む飲食品および香料

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU83350A1 (fr) 1981-05-08 1983-03-24 Oreal Composition destinee au traitement des fibres keratiniques a base de polymere cationique et de polymere anionique a groupements vinylsulfoniques et procede de traitement la mettant en oeuvre
IN162441B (no) 1984-12-26 1988-05-28 Council Scient Ind Res
US4842859A (en) * 1986-09-08 1989-06-27 Yaguang Liu Pharmaceutical compositions for reducing hyperlipidemia and platelet-aggregation
US5120538A (en) * 1990-02-05 1992-06-09 Pt Darya-Varia Laboratoria Combinations of compounds isolated from curcuma spp as anti-inflammatory agents
US5863938A (en) * 1991-03-01 1999-01-26 Warner Lambert Company Antibacterial-wound healing compositions and methods for preparing and using same
CN1100321A (zh) * 1994-03-27 1995-03-22 叶启智 灵猫香或其复方药用针剂
AU2300001A (en) * 1999-10-22 2001-05-08 Board Of Trustees Of The University Of Illinois, The Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease
DE10029770A1 (de) * 2000-06-16 2001-12-20 Transmit Technologietransfer Verwendung von Curcuminen zur Behandlung von soliden Tumoren,insbesondere von Hirntumoren
JP2002030081A (ja) * 2000-07-13 2002-01-29 Shiseido Co Ltd ジアリールヘプタノイド誘導体及びマトリックスメタロプロテアーゼ活性阻害剤
KR20020073847A (ko) * 2001-03-16 2002-09-28 주식회사 바이오시너젠 쿠르쿠민 또는 울금 추출물을 포함하는 치매 예방 및치료용 조성물

Also Published As

Publication number Publication date
US20100093870A1 (en) 2010-04-15
MXPA04005680A (es) 2004-10-15
CA2473874C (en) 2011-11-22
LT5284B (lt) 2005-11-25
AU2009212969A1 (en) 2009-10-01
CA2473874A1 (en) 2003-06-26
ZA200404648B (en) 2005-11-30
DE60233069D1 (de) 2009-09-03
NO332066B1 (no) 2012-06-18
GEP20084442B (en) 2008-08-10
EP1453528B1 (en) 2009-07-22
UA82057C2 (en) 2008-03-11
BR0214962A (pt) 2004-12-14
LT2004060A (en) 2005-06-27
EA200400807A1 (ru) 2004-12-30
CN100528149C (zh) 2009-08-19
JP2005516930A (ja) 2005-06-09
EE05374B1 (et) 2011-02-15
JP4695839B2 (ja) 2011-06-08
EA007067B1 (ru) 2006-06-30
WO2003051380A3 (en) 2004-06-17
KR20040073478A (ko) 2004-08-19
LV13250B (en) 2006-02-20
EE200400097A (et) 2004-10-15
CN1615144A (zh) 2005-05-11
AU2002348802A1 (en) 2003-06-30
KR101001815B1 (ko) 2010-12-15
WO2003051380A2 (en) 2003-06-26
EP1453528A2 (en) 2004-09-08
AU2009212969B2 (en) 2011-06-02
US20060051438A1 (en) 2006-03-09

Similar Documents

Publication Publication Date Title
NO20043000L (no) Et preparat for behandling av nevrocerebrovaskulaere sykdommer
NO20033594D0 (no) Fenetanolamin-derivater for behandling av luftveissykdommer
CY2014019I2 (el) Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου
NO20053077D0 (no) Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
NO20041882L (no) Fremgangsmater for behandling av okulare neovaskulaere sykdommer.
NO20044402L (no) Kombinasjonsbehandling av kemokine-medierte sykdommer
NO20031443L (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
NO20031442L (no) Morfolin-acetamidderivater for behandling av inflammatoriske sykdommer
NO20033143L (no) Farmasoytisk preparat
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20020133L (no) Preparat for behandling av utvortes sekresjonsforstyrrelser
AU2003219690A1 (en) Fused bicyclic-n-bridged-heteroaromatic carboxamides for the treatment of disease
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
NO20026008D0 (no) Fremgangsmåte for behandling av cardiovaskul¶re sykdommer
NO20031615L (no) Pyrazol-derivater for behandling av virus-sykdommer
NO20033205D0 (no) Terapeutiske kromanforbindelser
NO20034864D0 (no) Preparat for behandling av legemiddelindusert forstoppelse med 15-keto-prostaglandiner
NO20025805D0 (no) Farmasöytisk preparat
DE60236743D1 (de) Zur behandlung androgenabhängiger krankheiten
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
NO20035538D0 (no) Fremgangsmåte for fremstilling av zaleplon
NO20035586D0 (no) Fremgangsmåte for fremstilling av cykloheksanol-derivater
NO20042476L (no) Anvendelse av desoxypeganin for behandling av klinisk depresjon
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
NO20030717D0 (no) Forbindelser for behandling av avhengighetsforstyrrelser

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees